(5-Chlorobenzo[d][1,3]dioxol-4-yl)boronic acid, 98%, 100mg

alpha,alpha'-Dihydroxy-1,4-diisopropylbenzene>97.0%(GC)5g

2-Methyl-1,8-naphthyridine-3-carboxylic acid, 95.0%, 10g

1H-Pyrrole-2,5-dione, 1-[2-(2-hydroxyethoxy)ethyl]-, 95%+, 500mg

2-ethyl-1-(piperazin-1-yl)hexan-1-one, 95.0%, 1g

tert-Butyl (5-(trifluoromethyl)pyridin-3-yl)carbamate, 95.0%, 10g

(S)-3-((tert-Butoxycarbonyl)amino)-3-(naphthalen-1-yl)propanoic acid, 97%, 250mg

(R)-1-(3-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride, 97.0%, 250mg

2-[2-(3-CHLOROPHENYL)ETHYL]-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 97.0%, 1g

((4-Bromobenzyl)oxy)(tert-butyl)dimethylsilane, 95+%, 1g

2-Chloro-4-iodo-6-(trifluoromethyl)pyridine, 97.0%, 5g

(S)-2-((S)-2-Amino-3-phenylpropanamido)-3-hydroxypropanoic acid, 95.0%, 1g

3-Cyclohexyl-3-oxopropanenitrile, 95.0%, 1g